{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:04:03Z","timestamp":1782410643432,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4295-6","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T14:29:39Z","timestamp":1566916179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012\u20132017: a secondary dataset analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Marvellous","family":"Mhondoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nqobile","family":"Ndlovu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donewell","family":"Bangure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3570-2331","authenticated-orcid":false,"given":"Tsitsi","family":"Juru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Notion Tafara","family":"Gombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Shambira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nsubuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufuta","family":"Tshimanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"issue":"8 Pt 2","key":"4295_CR1","first-page":"567","volume":"101","author":"P Crowther-Gibson","year":"2011","unstructured":"Crowther-Gibson P, Govender N, Lewis DA, Bamford C, Brink A, von Gottberg A, et al. Part IV. Human infections and antibiotic resistance. S Afr Med J. 2011 Jul 28;101(8 Pt 2):567\u201378.","journal-title":"S Afr Med J"},{"key":"4295_CR2","unstructured":"Adeyi OO, Baris E, Jonas OB, Irwin A, Berthe FCJ, Gall L, et al. final report [Internet]. The World Bank; 2017 [cited 2018 May 17] p. 1\u2013172. Report No.: 114679. Available from: \n                    http:\/\/documents.worldbank.org\/curated\/en\/323311493396993758\/final-report"},{"key":"4295_CR3","unstructured":"WHO | Antimicrobial resistance: global report on surveillance 2014 [Internet]. WHO. [cited 2018 May 17]. Available from: \n                    http:\/\/www.who.int\/drugresistance\/documents\/surveillancereport\/en\/"},{"key":"4295_CR4","unstructured":"WHO | ANTIBACTERIAL AGENTS IN CLINICAL DEVELOPMENT [Internet]. WHO. [cited 2018 May 17]. Available from: \n                    http:\/\/www.who.int\/medicines\/areas\/rational_use\/antibacterial_agents_clinical_development\/en\/"},{"key":"4295_CR5","unstructured":"Africa CDC Antimicrobial Resistance Surveillance Network Launched during a Special Edition of ACDx Course [Internet]. M\u00e9rieux Foundation. 2013 [cited 2018 May 29]. Available from: \n                    https:\/\/www.fondation-merieux.org\/en\/news\/38-students-from-20-countries-took-our-advanced-course-on-diagnostics-acdx\/"},{"issue":"3","key":"4295_CR6","first-page":"229","volume":"7","author":"J Mbanga","year":"2010","unstructured":"Mbanga J, Dube S, Munyanduki H. Prevalence and drug resistance in bacteria of the urinary tract infections in Bulawayo province, Zimbabwe East. Afr J Public Health. 2010;7(3):229\u201332.","journal-title":"Afr J Public Health"},{"key":"4295_CR7","unstructured":"Mashe T, Mugabe M, Tarupiwa A, Stray-Pedersen B, Mbanga J. Antibiotic resistance trends of Salmonella typhi in Zimbabwe (2012 \u2013 2016). In 2016."},{"issue":"1","key":"4295_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3201\/eid2001.130732","volume":"20","author":"JZ Metcalfe","year":"2014","unstructured":"Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mungofa S, et al. Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerg Infect Dis. 2014 Jan;20(1):135\u20137.","journal-title":"Emerg Infect Dis"},{"key":"4295_CR9","unstructured":"Sustainable development goals - United Nations [Internet]. United Nations Sustainable Development. [cited 2018 May 17]. Available from: \n                    https:\/\/www.un.org\/sustainabledevelopment\/sustainable-development-goals\/"},{"key":"4295_CR10","unstructured":"Population Census Vital | Zimbabwe National Statistics [Internet]. [cited 2018 Jun 12]. Available from: \n                    http:\/\/www.zimstat.co.zw\/population-census-vital\n                    \n                  ."},{"key":"4295_CR11","unstructured":"SITUATION-ANALYSIS-OF-ANTIMICROBIAL-USE-AND-RESISTANCE-IN-HUMANS-AND-ANIMALS-IN-ZIMBABWE-1.pdf [Internet]. [cited 2018 May 17]. Available from: \n                    https:\/\/cddep.org\/wp-content\/uploads\/2017\/10\/SITUATION-ANALYSIS-OF-ANTIMICROBIAL-USE-AND-RESISTANCE-IN-HUMANS-AND-ANIMALS-IN-ZIMBABWE-1.pdf"},{"issue":"6","key":"4295_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2042098614554919","volume":"5","author":"C Llor","year":"2014","unstructured":"Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229\u201341.","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"4295_CR13","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis. P T. 2015;40(4):277\u201383.","journal-title":"P T"},{"key":"4295_CR14","unstructured":"Antimicrobial resistance [Internet]. World Health Organization. [cited 2018 May 29]. Available from: \n                    http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"issue":"3","key":"4295_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3343\/alm.2017.37.3.231","volume":"37","author":"D Kim","year":"2017","unstructured":"Kim D, Ahn JY, Lee CH, Jang SJ, Lee H, Yong D, et al. Increasing resistance to extended-Spectrum Cephalosporins, fluoroquinolone, and Carbapenem in gram-negative bacilli and the emergence of Carbapenem non-susceptibility in Klebsiella pneumoniae: analysis of Korean antimicrobial resistance monitoring system (KARMS) data from 2013 to 2015. Ann Lab Med. 2017;37(3):231\u20139.","journal-title":"Ann Lab Med"},{"issue":"3","key":"4295_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JDD Pitout","year":"2008","unstructured":"Pitout JDD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159\u201366.","journal-title":"Lancet Infect Dis"},{"key":"4295_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13756-016-0155-y","volume":"6","author":"MT Magwenzi","year":"2017","unstructured":"Magwenzi MT, Gudza-Mugabe M, Mujuru HA, Dangarembizi-Bwakura M, Robertson V, Aiken AM. Carriage of antibiotic-resistant Enterobacteriaceae in hospitalised children in tertiary hospitals in Harare, Zimbabwe. Antimicrob Resist Infect Control. 2017;6:10.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"7","key":"4295_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.medmal.2018.02.005","volume":"48","author":"L Armand-Lef\u00e8vre","year":"2018","unstructured":"Armand-Lef\u00e8vre L, Andremont A, Rupp\u00e9 E. Travel and acquisition of multidrug-resistant Enterobacteriaceae. Med Mal Infect. 2018;48(7):431\u201341.","journal-title":"Med Mal Infect"},{"issue":"15","key":"4295_CR19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.286.15.1849","volume":"286","author":"JF Piccirillo","year":"2001","unstructured":"Piccirillo JF, Mager DE, Frisse ME, Brophy RH, Goggin A. Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis. JAMA. 2001;286(15):1849\u201356.","journal-title":"JAMA."},{"key":"4295_CR20","doi-asserted-by":"crossref","unstructured":"Osei Sekyere J. Current State of Resistance to Antibiotics of Last-Resort in South Africa: A Review from a Public Health Perspective. Front Public Health [Internet]. 2016 Sep 30 [cited 2018 May 18];4. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5042966\/","DOI":"10.3389\/fpubh.2016.00209"},{"issue":"4","key":"4295_CR21","first-page":"273","volume":"97","author":"A Brink","year":"2007","unstructured":"Brink A, Moolman J, da Silva MC, Botha M. National antibiotic surveillance forum. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. S Afr Med J. 2007;97(4):273\u20139.","journal-title":"S Afr Med J"},{"key":"4295_CR22","unstructured":"WHO publishes list of bacteria for which new antibiotics are urgently needed [Internet]. World Health Organization. [cited 2018 May 29]. Available from: \n                    http:\/\/www.who.int\/news-room\/detail\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed"},{"key":"4295_CR23","unstructured":"Carbapenem Resistance: A Review [Internet]. [cited 2019 Apr 18]. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5872158\/\n                    \n                  ."},{"issue":"7","key":"4295_CR24","doi-asserted-by":"publisher","first-page":"e68024","DOI":"10.1371\/journal.pone.0068024","volume":"8","author":"ME Falagas","year":"2013","unstructured":"Falagas ME, Karageorgopoulos DE, Leptidis J, Korbila IP. MRSA in Africa: filling the global map of antimicrobial resistance. PLoS One. 2013;8(7):e68024.","journal-title":"PLoS One"},{"issue":"1","key":"4295_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ajic.2016.08.010","volume":"45","author":"ME Evans","year":"2017","unstructured":"Evans ME, Kralovic SM, Simbartl LA, Jain R, Roselle GA. Eight years of decreased methicillin-resistant Staphylococcus aureus health care-associated infections associated with a veterans affairs prevention initiative. Am J Infect Control. 2017;45(1):13\u20136.","journal-title":"Am J Infect Control"},{"issue":"suppl_1","key":"4295_CR26","doi-asserted-by":"publisher","first-page":"i23","DOI":"10.1093\/jac\/dkt023","volume":"68","author":"PRS Lagac\u00e9-Wiens","year":"2013","unstructured":"Lagac\u00e9-Wiens PRS, Adam HJ, Low DE, Blondeau JM, Baxter MR, Denisuik AJ, et al. Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007\u201311. J Antimicrob Chemother. 2013;68(suppl_1):i23\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"4295_CR27","unstructured":"Epidemiology of Staphylococcus aureus Blood and Skin and Soft Tissue Infections in the US Military Health System, 2005-2010 | Critical Care Medicine | JAMA | JAMA Network [Internet]. [cited 2018 May 22]. Available from: \n                    https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/1212307"},{"key":"4295_CR28","unstructured":"Guidelines for the Management of Typhoid Fever. Zimbabwe, 2011 [Internet]. [cited 2018 May 18]. Available from: \n                    http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js20994en\/\n                    \n                  ."},{"key":"4295_CR29","unstructured":"Microbiology Society Journals | Trends in fluoroquinolone resistance in Campylobacter [Internet]. [cited 2019 Apr 18]. Available from: \n                    https:\/\/mgen.microbiologyresearch.org\/content\/journal\/mgen\/10.1099\/mgen.0.000198\n                    \n                  ."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4295-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:09:16Z","timestamp":1598396956000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4295-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4295"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4295-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"8 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Lancet Clinical laboratory management and the Health Studies Office in the Ministry of Health Institutional Review Board. The board waived the need for informed consent due to the retrospective nature of the study, however we did not use patients\u2019 information in this study as it was anonymised by use of patient account numbers. Data was kept safe and confidential and only used for this study. Administrative permission to access data was requested through the laboratory manager of Lancet Clinical laboratories Zimbabwe and granted by the Consultant Microbiologist and Information Systems Consultant at Lancet South Africa.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"746"}}